Met amplification and tumor progression in Cdkn2a-deficient melanocytes

While many genetic alterations have been identified in melanoma, the relevant molecular events that contribute to disease progression are poorly understood. Most primary human melanomas exhibit loss of expression of the CDKN2A locus in addition to activation of canonical MAPK signaling including RAS...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: VanBrocklin, Matthew W., Robinson, James P., Whitwam, Todd, Guilbeault, Adam R., Koeman, Julie, Swiatek, Pamela J., Vande Woude, George F., Khoury, Joseph D., Holmen, Sheri L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2775091/
https://ncbi.nlm.nih.gov/pubmed/19422607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-148X.2009.00576.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller